Prognostic Markers in Peripheral Blood Shine Light on Future Directions in NSCLC
Joseph Christopher Murray, MD, discusses the role of prognostic markers in non–small cell lung cancer and how data from the EMPOWER trials will guide future directions in the space.
Source: onclive.com